Bevacizumab Neoadjuvant Therapy for New High-grade Gliomas in the Brain
Bevacizumab Neoadjuvant Therapy for New High-grade Gliomas in the Brain
Recruiting · NCT06747728 · Registry updated 2024-12-24Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Bevacizumab Neoadjuvant Therapy for New High-grade Gliomas in the Brain | brain glioma | Recruiting | Not applicable | 2024-12-24 | NCT06747728 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| The First Affiliated Hospital of Zhengzhou University | 203 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| The First Affiliated Hospital of Zhengzhou University | Zhengzhou | China | 103 |